Primary prevention of type-2 diabetes in developing countries

Journal of the National Medical Association

Volumn 98, Issue 3, 2006, Pages 415-419

  Dagogo Jack, Samuel ^a,b  

^a University of Tennessee Health Science Center ^*

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Developing countries; Diabetes; Prevention

Indexed keywords

METFORMIN;

AFRICA SOUTH OF THE SAHARA; AFRICAN AMERICAN; AMPUTATION; ARTICLE; CARIBBEAN ISLANDS; CHINA; COST OF ILLNESS; DEVELOPING COUNTRY; EDUCATION PROGRAM; FUNDING; GOVERNMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HEART DISEASE; HUMAN; INDIA; INFORMATION DISSEMINATION; INFORMATION SERVICE; KIDNEY FAILURE; LIFESTYLE; MONEY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGENY; RESOURCE ALLOCATION;

DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; HUMANS; PRIMARY PREVENTION;

EID: 33644806599     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Diabetes Association: diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1)S5-S10.
2. Rosenbloom AL, Joe JR, Young RS, et al. Emerging epidemic of type 2 diabetes in youth, Diabetes Care. 1999;22:345-354.
3. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002;15(Suppl 2):737-744.
4. Moneva M, Dagogo-Jack S. Multiple drug targets in the management of type 2 diabetes mellitus. Curr Drug Targets. 2002;3:203-221.
5. Vaag A, Henriksen JE, Madsbad S, et al. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest. 1995;95:690-698.
6. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: Pathophysiology and implications for prevention and management. J Natl Med Assoc. 2003;95:774-789.
7. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
8. Osei K, Schuster DP, Owusu SK, et al. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans. Metabolism. 1997;46:53-58.
9. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. Diabetes. 1996;45:742-748.
10. Mbanya JC, Cruickshank JK, Forrester T, et al. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999;22:434-440.
11. Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes. 1988;37:622-628.
12. Prentice AM, Moore SE. Early programming of adult diseases in resource poor countries. Arch Dis Child. 2005;90:429-432.
13. Dagogo-Jack S. Pattern of foot ulcer in diabetic Nigerians. Practical Diabetes Digest. 1991;2:75-78.
14. Dagogo-Jack S. Diabetic in-patient mortality in Nigeria. Practical Diabetes Digest. 1991;2:117-119.
15. Deeb LC, Tan MH, Alberti KGMM. Insulin availability among International Diabetes Federation member associations. Diabetes Care. 1994;17:220-223.
16. Dagogo-Jack S. DCCT results and diabetes care in developing countries. Diabetes Care. 1995;18:416-417.
17. Clemmesen J. Kaposi sarcoma in homosexual men: is it a new disease? Lancet. 1982;2:51-52.
18. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
19. Tuomilehto J, Lindstrom J, Eriksson JG, et al., Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
20. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
21. Dagogo-Jack S. Experience with the organization of a local diabetic association in Port Harcourt, Nigeria. Pract Diabetes Dig. 1990;1:145-147.
22. Herman WH, Brandle M, Zhang P, et al., Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26:36-47.
23. The Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26:2518-2523.